These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15989462)

  • 1. Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.
    Farrow MA; Somasundaran M; Zhang C; Gabuzda D; Sullivan JL; Greenough TC
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):565-74. PubMed ID: 15989462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS.
    Sakurai A; Jere A; Yoshida A; Yamada T; Iwamoto A; Adachi A; Fujita M
    Microbes Infect; 2004 Jul; 6(9):799-805. PubMed ID: 15374001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein.
    Friedler A; Zakai N; Karni O; Friedler D; Gilon C; Loyter A
    J Mol Biol; 1999 Jun; 289(3):431-7. PubMed ID: 10356319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation.
    Fujita M; Akari H; Sakurai A; Yoshida A; Chiba T; Tanaka K; Strebel K; Adachi A
    Microbes Infect; 2004 Jul; 6(9):791-8. PubMed ID: 15374000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity.
    Khamsri B; Fujita M; Kamada K; Piroozmand A; Yamashita T; Uchiyama T; Adachi A
    Int J Mol Med; 2006 Oct; 18(4):679-83. PubMed ID: 16964423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
    Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
    J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
    J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.
    Ma XY; Sova P; Chao W; Volsky DJ
    J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions.
    Paul I; Cui J; Maynard EL
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18475-80. PubMed ID: 17132731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique characteristics of HIV-1 Vif expression.
    Wang H; Sakurai A; Khamsri B; Uchiyama T; Gu H; Adachi A; Fujita M
    Microbes Infect; 2005 Mar; 7(3):385-90. PubMed ID: 15784183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.
    Fujita M; Sakurai A; Yoshida A; Miyaura M; Koyama AH; Sakai K; Adachi A
    J Virol; 2003 Jan; 77(2):1626-32. PubMed ID: 12502880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity.
    Aires da Silva F; Santa-Marta M; Freitas-Vieira A; Mascarenhas P; Barahona I; Moniz-Pereira J; Gabuzda D; Goncalves J
    J Mol Biol; 2004 Jul; 340(3):525-42. PubMed ID: 15210352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
    Ochsenbauer C; Wilk T; Bosch V
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.